Fir Tree Capital Management’s NKGen Biotech, Inc. Warrants NKGNW Stock Holding History

Fir Tree Capital Management’s Portfolio NKGNW Stock Details NKGNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-49,160	Closed	-$7K	–	368
2022 Q3	$7K	Sell	49,160 -50,840	-51%	-$8.75K	﹤0.01%	517
2022 Q2	$26K	Hold	100,000	–	–	﹤0.01%	569
2022 Q1	$61K	Hold	100,000	–	–	﹤0.01%	584
2021 Q4	$115K	Hold	100,000	–	–	﹤0.01%	578
2021 Q3	$116K	Buy	+100,000	New	+$125K	﹤0.01%	460

Other funds holding NKGNW

RCM

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

DCM

Difesa Capital Management New York $38.1M AUM 39.86% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Fir Tree Capital Management's NKGNW Position: Q4 2022 in Review

Fir Tree Capital Management sold out of NKGen Biotech, Inc. Warrants (NKGNW) in Q4 2022, closing a stake of 49,160 shares — an estimated $7K sold.

Fir Tree Capital Management first reported a position in NKGNW in Q3 2021 and held it in 5 quarters. The position peaked at $116K in Q3 2021. 38 funds tracked by Wall St. Rank hold NKGNW as of Q4 2022.

Fir Tree Capital Management reported no remaining NKGen Biotech, Inc. Warrants position as of Q4 2022 after selling out during the quarter.
Fir Tree Capital Management sold 49,160 NKGen Biotech, Inc. Warrants shares in Q4 2022, an estimated $7K.
Fir Tree Capital Management first reported a position in NKGen Biotech, Inc. Warrants in Q3 2021 and held it in 5 quarters.
Fir Tree Capital Management's NKGen Biotech, Inc. Warrants position peaked at $116K in Q3 2021.
38 funds tracked by Wall St. Rank held NKGen Biotech, Inc. Warrants as of Q4 2022.

Based on Fir Tree Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.